📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Swedish healthcare firm Capio to sell French business to Vivalto Sante

Published 21/08/2018, 09:02
© Reuters.  Swedish healthcare firm Capio to sell French business to Vivalto Sante

STOCKHOLM (Reuters) - Swedish healthcare company Capio (ST:CAPIO) plans to sell its French business to Vivalto Sante in a deal worth up to 455 million euros (408.05 million pounds)to focus on its less capital intensive Nordic operations.

Capio, which operates in Sweden, Norway, Denmark, France and Germany and had net sales of 15.3 billion crowns ($1.67 billion) last year, had said in June it was in talks on a possible divestment of its non-Nordic operations.

"The proposed transaction would accelerate the positioning towards the less capital intensive Nordic operations and build on Capio's leadership positions to further drive growth and shareholder value," Capio said in a statement.

The consideration for the proposed deal would be an upfront enterprise value of 425 million euros plus an earn-out contingent on this year's financial performance, up to a total enterprise value of 455 million.

The deal is subject to due diligence of Capio France by Vivalto, the approval of regulatory authorities and the approval of Capio's shareholders at an extraordinary general meeting, it said.

"It is anticipated that proceeds from a sale would be used partly to pay down Capio Group debt and partly as a return of cash to shareholders," the company said.

In July, Capio's board turned down a 661 million euro takeover offer for the whole group from the French subsidiary of Australian hospital group Ramsay Health Care (AX:RHC) (PA:GDSF), saying it undervalued its business.

Capio shares were up 1.75 percent at 0733 GMT.

($1 = 0.8744 euros)

($1 = 9.1511 Swedish crowns)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.